CAS: 3587-64-2; 1-Methoxy-2-Methyl-2-Propanol

相似化合物

558-43-0 26550-55-0 107-98-2

上下游产品

2-methyl-1,2-epoxypropane methanol sodium methylate 3-chloro-2-methylpropan-2-ol Dimethyl-methoxymethyl-carbinyl-acetat isobutyraldehyde Nd(mmp)3 La(mmp)3

甲氧基乙酸甲酯置于甲基碘化镁体系中,化学反应生成1-甲氧基-2-甲基-2-丙醇
参考文献:Palomaa,Chemisches Zentralblatt,1918,Vol. 89,# I,P. 1144
标题:Palomaa,Chemisches Zentralblatt,1918,Vol. 89,# I,P. 1144

专利信息

专利号:US-11491263-B2
优先权日:2017-06-01
标 题:Controllable ion release calcium particles, method for producing same and use thereof
发明人：ENGEL LOPEZ ELISABETH; CASTANO LINARES OSCAR; MARTI MUNOZ JOAN; PLANELL ESTANY JOSEP ANTON
权利人:FUNDACIO INST DE BIOENGINYERIA DE CATALUNYA IBEC; UNIV CATALUNYA POLITECNICA
摘要:The present invention refers to a method for the synthesis of a biodegradable calcium release material that shows controlled ion release properties for tissue engineering, biomaterials containing the calcium particles as well as the calcium particles obtainable therefrom. By varying the treatment temperature of the described method, the calcium material shows different calcium release profiles. Contrary to a specific chemical composition such as CaCO 3 which is associated to a specific calcium release profile, the present invention allows a manifold of compositions, with a manifold of calcium release profiles, all starting from a single specific chemical composition calcium precursor. Therefore, the invention also relates to the use of the controllable release, calcium material in tissue regeneration such as wound healing processes.

专利号:US-8987195-B2
优先权日:2012-08-08
标 题:HCV NS3 protease inhibitors
发明人：BARA THOMAS; BHAT SATHESH; BISWAS DIPSHIKHA; BROCKUNIER LINDA; BURNETT DUANE A; CHACKALAMANNIL SAMUEL; CHELLIAH MARIAPPAN V; CHEN AUSTIN; CLASBY MARTIN; COLANDREA VINCE J; GUO ZHUYAN; HAN YONGXIN; JAYNE CHARLES; JOSIEN HUBERT; MARCANTONIO KAREN; MIAO SHOUWU; NEELAMKAVIL SANTHOSH; PINTO PATRICK; RAJAGOPALAN MURALI; SHAH UNMESH; VELAZQUEZ FRANCISCO; VENKATRAMAN SRIKANTH; XIA YAN
权利人:MERCK SHARP & DOHME; MERCK CANADA INC
摘要:The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.

专利号:US-9617251-B2
优先权日:2015-08-07
标题:Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
发明人：ECKHARDT MATTHIAS; PETERS STEFAN; WAGNER HOLGER
权利人:BOEHRINGER INGELHEIM INT
摘要:The present invention relates to compounds of general formula I, n nwherein the groups R, R 1 , R 2 , R 3 , m and n are defined as in claim 1 , which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

专利号:US-11306091-B2
优先权日:2019-06-25
标 题 :Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon
发明人：CHI DAE YOON; LEE BYOUNG SE; CHU SO YOUNG; JEONG HYEON JIN; KIM HYEON SEOK
权利人:FUTURECHEM CO LTD
摘要:The present invention relates to a process for producing an organofluoro compound including [18F]fluorine, and by using a solvent represented by Formula 1 in nucleophilic fluorination reaction, an organofluoro compound may be prepared at a high yield. In addition, since the solvent has very excellent solubility for a precursor compound, the solvent is suitable for the automated synthesis of 18F-labeled radiopharmaceuticals.

专利号:RU-2164229-C2
优先权日:1994-10-19
标 题 :Antiviral substrate isoster esters of aspartate protease or their salts, method of their synthesis, pharmaceutical preparation and composition

专利号:US-2024124517-A1
优先权日:2020-12-25
标题:Method for producing peptide compound containing n-substituted-amino acid residue
发明人：MORITA YUYA; NOMURA KENICHI
权利人:CHUGAI PHARMACEUTICAL CO LTD
摘要:An object of the present invention is to provide a method for efficiently producing a high-purity peptide compound with a high yield. It has been found that the object can be achieved by supporting a peptide on a solid phase synthesis resin prior to a first elongation reaction in a solid phase process.